Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Use of Nitrosative Stress Molecules as Potential Diagnostic Biomarkers in Multiple Sclerosis.
Räuber S, Förster M, Schüller J, Willison A, Golombeck KS, Schroeter CB, Oeztuerk M, Jansen R, Huntemann N, Nelke C, Korsen M, Fischer K, Kerkhoff R, Leven Y, Kirschner P, Kölsche T, Nikolov P, Mehsin M, Marae G, Kokott A, Pul D, Schulten J, Vogel N, Ingwersen J, Ruck T, Pawlitzki M, Meuth SG, Melzer N, Kremer D. Räuber S, et al. Among authors: ingwersen j. Int J Mol Sci. 2024 Jan 8;25(2):787. doi: 10.3390/ijms25020787. Int J Mol Sci. 2024. PMID: 38255863 Free PMC article.
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab.
Räuber S, Korsen M, Huntemann N, Rolfes L, Müntefering T, Dobelmann V, Hermann AM, Kölsche T, von Wnuck Lipinski K, Schroeter CB, Nelke C, Regner-Nelke L, Ingwersen J, Pawlitzki M, Teegen B, Barnett MH, Hartung HP, Aktas O, Albrecht P, Levkau B, Melzer N, Ruck T, Meuth SG, Kremer D. Räuber S, et al. Among authors: ingwersen j. J Neurol Neurosurg Psychiatry. 2022 Sep;93(9):978-985. doi: 10.1136/jnnp-2021-328197. Epub 2022 Feb 22. J Neurol Neurosurg Psychiatry. 2022. PMID: 35193952 Free PMC article.
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.
Rolfes L, Pawlitzki M, Pfeuffer S, Nelke C, Lux A, Pul R, Kleinschnitz C, Kleinschnitz K, Rogall R, Pape K, Bittner S, Zipp F, Warnke C, Goereci Y, Schroeter M, Ingwersen J, Aktas O, Klotz L, Ruck T, Wiendl H, Meuth SG. Rolfes L, et al. Among authors: ingwersen j. Neurol Neuroimmunol Neuroinflamm. 2021 Jul 14;8(5):e1035. doi: 10.1212/NXI.0000000000001035. Print 2021 Sep. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34261812 Free PMC article.
Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls.
Räuber S, Nelke C, Schroeter CB, Barman S, Pawlitzki M, Ingwersen J, Akgün K, Günther R, Garza AP, Marggraf M, Dunay IR, Schreiber S, Vielhaber S, Ziemssen T, Melzer N, Ruck T, Meuth SG, Herty M. Räuber S, et al. Among authors: ingwersen j. Front Immunol. 2023 Aug 1;14:1198860. doi: 10.3389/fimmu.2023.1198860. eCollection 2023. Front Immunol. 2023. PMID: 37600819 Free PMC article.
CNS Involvement in Chronic Inflammatory Demyelinating Polyneuropathy: Subtle Retinal Changes in Optical Coherence Tomography.
Ingwersen J, Graf J, Kluge J, Weise M, Dietrich M, Lee JI, Harmel J, Hartung HP, Ruck T, Meuth SG, Albrecht P, Aktas O, Ringelstein M. Ingwersen J, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Oct 19;9(1):e1099. doi: 10.1212/NXI.0000000000001099. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34667130 Free PMC article.
Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab.
Pfeuffer S, Rolfes L, Ingwersen J, Pul R, Kleinschnitz K, Korsen M, Räuber S, Ruck T, Schieferdecker S, Willison AG, Aktas O, Kleinschnitz C, Hartung HP, Kappos L, Meuth SG. Pfeuffer S, et al. Among authors: ingwersen j. Neurol Neuroimmunol Neuroinflamm. 2023 Apr 11;10(3):e200104. doi: 10.1212/NXI.0000000000200104. Print 2023 May. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37041077 Free PMC article.
Prevalence and prognostic value of neurological affections in hospitalized patients with moderate to severe COVID-19 based on objective assessments.
Balloff C, Bandlow C, Bernhard M, Brandenburger T, Bludau P, Elben S, Feldt T, Hartmann CJ, Heinen E, Ingwersen J, Jansen C, Jensen BO, Kindgen-Milles D, Luedde T, Penner IK, Slink I, Stramm K, Telke AK, Timm J, Vetterkind L, Vollmer C, Wolff G, Schnitzler A, Meuth SG, Groiss SJ, Albrecht P. Balloff C, et al. Among authors: ingwersen j. Sci Rep. 2023 Nov 10;13(1):19619. doi: 10.1038/s41598-023-46124-w. Sci Rep. 2023. PMID: 37949882 Free PMC article.
45 results